These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7541585)

  • 1. Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men.
    Mermall H; Sothern RB; Kanabrocki EL; Quadri SF; Bremner FW; Nemchausky BA; Scheving LE
    Urology; 1995 Jul; 46(1):45-53. PubMed ID: 7541585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic variations of serum testosterone within the normal range do not affect serum prostate-specific antigen.
    Monath JR; McCullough DL; Hart LJ; Jarow JP
    Urology; 1995 Jul; 46(1):58-61. PubMed ID: 7541587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
    Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
    J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
    Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
    Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL.
    Kravchick S; Peled R; Dorfman D; Agulansky L; Ben-Dor D; Cytron S
    Urology; 2005 Sep; 66(3):542-6. PubMed ID: 16140074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration.
    Monda JM; Myers RP; Bostwick DG; Oesterling JE
    Urology; 1995 Jul; 46(1):62-4. PubMed ID: 7541588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rigorous bicycling does not increase serum levels of total and free prostate-specific antigen (PSA), the free/total PSA ratio, gonadotropin levels, or uroflowmetric parameters.
    Saka T; Sofikerim M; Demirtas A; Kulaksizoglu S; Caniklioglu M; Karacagil M
    Urology; 2009 Dec; 74(6):1325-30. PubMed ID: 19781750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen variation in patients without clinically evident prostate cancer.
    Lujan M; Paez A; Sanchez E; Herrero A; Martin E; Berenguer A
    J Urol; 1999 Oct; 162(4):1311-3. PubMed ID: 10492186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ejaculation increases the serum prostate-specific antigen concentration.
    Tchetgen MB; Song JT; Strawderman M; Jacobsen SJ; Oesterling JE
    Urology; 1996 Apr; 47(4):511-6. PubMed ID: 8638359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone.
    Akyol F; Ozyigit G; Selek U; Karabulut E
    Eur Urol; 2005 Jul; 48(1):40-5. PubMed ID: 15967250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
    Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
    Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of cyproterone acetate in achieving castration and preventing luteinizing hormone releasing hormone analogue induced testosterone surge in patients with prostate cancer.
    Appu S; Lawrentschuk N; Grills RJ; Neerhut G
    J Urol; 2005 Jul; 174(1):140-2. PubMed ID: 15947599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flexible cystoscopy on serum prostate-specific antigen values.
    DeCastro BJ; Baker KC
    Urology; 2009 Feb; 73(2):237-40. PubMed ID: 19041123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
    Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
    Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of age on serum prostate specific antigen concentration].
    Wang Z; Liu D; Zhau L
    Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):368-9. PubMed ID: 9594181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
    Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.